(Q33990663)

30 July 2017

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals (English)

1 reference

Alzheimer's Disease Neuroimaging Initiative

30 July 2017

0 references

5

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

30 July 2017

2

J W Bartlett

1 reference

30 July 2017

8

H Zetterberg

1 reference

30 July 2017

3

K Blennow

1 reference

30 July 2017

7

J Q Trojanowski

1 reference

30 July 2017

R W Paterson

1

1 reference

30 July 2017

N C Fox

4

1 reference

30 July 2017

L M Shaw

6

1 reference

30 July 2017

J M Schott

9

1 reference

30 July 2017

29 July 2014

1 reference

30 July 2017

Translational Psychiatry

1 reference

30 July 2017

4

1 reference

30 July 2017

e419

1 reference

Creative Commons Attribution 3.0 Unported

30 July 2017

start time

1 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/tp.2014.58

0 references

cites work

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Microglial chemotactic signaling factors in Alzheimer's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Patterns of atrophy differ among specific subtypes of mild cognitive impairment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Imaging cerebral atrophy: normal ageing to Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Controlling the false discovery rate in behavior genetics research

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Correlation between rates of brain atrophy and cognitive decline in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Trefoil factor family (TFF) expression in the mouse brain and pituitary: changes in the developing cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Neuropeptide Trefoil factor 3 improves learning and retention of novel object recognition memory in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Cystatin C in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.58

Age of onset and brain atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4119225

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25072324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25072324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/TP.2014.58

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference